These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21235809)

  • 1. Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson's rats: effect of 5-HT, GABA and bone marrow cell supplementation.
    Nandhu MS; Paul J; Kuruvilla KP; Malat A; Romeo C; Paulose CS
    J Biomed Sci; 2011 Jan; 18(1):5. PubMed ID: 21235809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate and NMDA receptors activation leads to cerebellar dysfunction and impaired motor coordination in unilateral 6-hydroxydopamine lesioned Parkinson's rat: functional recovery with bone marrow cells, serotonin and GABA.
    Nandhu MS; Paul J; Kuruvila KP; Abraham PM; Antony S; Paulose CS
    Mol Cell Biochem; 2011 Jul; 353(1-2):47-57. PubMed ID: 21384157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D1 receptor gene expression studies in unilateral 6-hydroxydopamine-lesioned Parkinson's rat: effect of 5-HT, GABA, and bone marrow cell supplementation.
    Nandhu MS; Fabia ET; Paulose CS
    J Mol Neurosci; 2010 May; 41(1):1-11. PubMed ID: 19578995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
    Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
    J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra.
    Andringa G; van Oosten RV; Unger W; Hafmans TG; Veening J; Stoof JC; Cools AR
    Eur J Neurosci; 2000 Aug; 12(8):3033-43. PubMed ID: 10971644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis.
    Galeffi F; Bianchi L; Bolam JP; Della Corte L
    Eur J Neurosci; 2003 Aug; 18(4):856-68. PubMed ID: 12925011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of lesions in the compact part of the substantia nigra on glutamate and GABA release in the pedunculopontine nucleus].
    Blanco-Lezcano L; Rocha-Arrieta LL; Alvarez-González L; Martínez-Martí L; Pavón-Fuentes N; González-Fraguela ME; Bauzá-Calderín Y; Coro-Grave de Peralta Y
    Rev Neurol; 2005 Jan 1-15; 40(1):23-9. PubMed ID: 15696422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat.
    Rangel-Barajas C; Silva I; García-Ramírez M; Sánchez-Lemus E; Floran L; Aceves J; Erlij D; Florán B
    Neuropharmacology; 2008 Oct; 55(5):704-11. PubMed ID: 18588904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats.
    Kim YK; Lim HH; Song YK; Lee HH; Lim S; Han SM; Kim CJ
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):133-8. PubMed ID: 15893426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
    Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
    Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the motor cortical and striatal glutamatergic system and D-serine levels in the bilateral 6-hydroxydopamine rat model for Parkinson's disease.
    El Arfani A; Albertini G; Bentea E; Demuyser T; Van Eeckhaut A; Smolders I; Massie A
    Neurochem Int; 2015 Sep; 88():88-96. PubMed ID: 26172319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
    Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT
    J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety-like behavior induced by 6-OHDA animal model of Parkinson's disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety.
    Vieira JCF; Bassani TB; Santiago RM; de O Guaita G; Zanoveli JM; da Cunha C; Vital MABF
    Behav Brain Res; 2019 Oct; 371():111981. PubMed ID: 31141725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
    Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
    PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P; Mercuri NB; Sancesario G; Bernardi G
    Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease.
    Ishida Y; Todaka K; Kuwahara I; Ishizuka Y; Hashiguchi H; Nishimori T; Mitsuyama Y
    Brain Res; 1998 Oct; 809(1):107-14. PubMed ID: 9795171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.
    Decressac M; Mattsson B; Björklund A
    Exp Neurol; 2012 May; 235(1):306-15. PubMed ID: 22394547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
    Ochi M; Shiozaki S; Kase H
    Neuroscience; 2004; 127(1):223-31. PubMed ID: 15219684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model.
    Park HJ; Lim S; Joo WS; Yin CS; Lee HS; Lee HJ; Seo JC; Leem K; Son YS; Kim YJ; Kim CJ; Kim YS; Chung JH
    Exp Neurol; 2003 Mar; 180(1):93-8. PubMed ID: 12668152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.